Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement

Weight loss

Yesterday

Novo Nordisk global chief executive Maziar Mike Doustdar started work at the pharmaceutical company as a clerk.

Lean profits, leaner CEO: Inside the Novo Nordisk miracle

The global chief executive of weight loss drug giant Novo Nordisk, Mike Doustdar, lost 25 kilos – but he did it the old-fashioned way.

This Month

Our bodies cannot be controlled the way we want them to.

There’s no shortcut to being skinny or young. Why do we keep trying?

Even as plastic surgery and GLP-1 drugs become more normalised, there are limits to what they can do.

Experts don’t know whether people taking GLP-1s lose more muscle, less or just the right amount relative to other forms of weight loss – or even if what’s lost is healthy muscle tissue.

Why you shouldn’t panic about GLP-1 muscle loss

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

People taking GLP-1 weight-loss drugs are undergoing a “psychological shift”.

They hated exercise. Weight-loss drugs changed everything

For some people, the medications have transformed their relationship with physical activity.

Eli Lilly and Novo Nordisk are in a tussle for dominance of the global oral GLP-1 market.

Eli Lilly confirms oral GLP-1 weight-loss drug being evaluated by TGA

The expected launch of a second oral GLP-1 in the United States has sparked major interest in Australia.

Advertisement

February

Sigma Healthcare chief executive Vikesh Ramsunder says the popularity of weight-loss drugs is driving sales growth.

Weight-loss drugs drive double-digit Chemist Warehouse sales

The popularity of the medication is boosting sales in hair and beauty products at the pharmacies giant, and a new oral version will drive demand even higher.

Large meals are shrinking.

Super-size meals ending in Make America Healthy Again

Cash-strapped US consumers are seeking cheaper options as the cost of living rises and weight-loss drugs become more available.

zfd

Intermittent fasting no better than dieting, study finds

Debate about the best slimming strategies is set to intensify after research revealed intermittent fasting is not the miracle solution people thought it was.

While drugs like Ozempic and Mounjaro can help people lose weight, they sometimes make them look older in the process.

Starving to death: Malnutrition risk from weight loss drugs

An Australian-led study suggests dietary intake and nutrition are being ignored in global studies of GLP-1s, which could result in malnutrition, even scurvy.

January

Jeff Bezos and Lauren Sanchez wedding pre wedding reception arrivals

Thanks to Ozempic, we’ve entered fashion’s new age of reconstruction

From corsets to bustles and oversized panniers, the female form is being exaggerated – or distorted – like never before. What exactly is going on?

Instagram’s dad-bod busting, energy boosting pills are all about vibes

For $1000 a year, these supplements can manifest a jawline and stop menopause pain. But why are these Australian natural remedies all registered in Wyoming?

Screen shots of advertisements circulating on Instagram from companies promoting weight loss programs and the promotion of GLP-1s.

Weight-loss ad blitz prompts warning from doctors

Social media feeds are being flooded with advertisements for weight-loss programs, which doctors say are skirting laws that ban direct advertising of medicines.

Tim Doyle’s Eucalyptus operates online health brands Juniper, Pilot, Software and Kin, which offer digital consultations to treat a range of conditions, but is best known for offering weight loss drugs.

Medical staff accuse Eucalyptus of overwork and underpay

Eucalyptus’ medical assistants in Manila claim the heavily backed start-up has presided over a culture of overwork and toxicity as it closes in on a $1.37 billion valuation.

New pill forms of popular weight loss injections will make the drugs cheaper, but still confined to the rich.

Weight-loss drug wealth divide drives push for cheaper jabs

Australians pay less for weight-loss drugs than many other countries, but prices could be coming down as drug companies develop pill alternatives to injections.

The federal government wants more advice before deciding whether to back broader subsidies for weight loss drugs.

Doctors divided on push for taxpayer-funded weight-loss drugs

Labor is considering advice to subsidise weight-loss drugs for obese people with heart disease, but doctors say more people need access to cheaper treatments.

Advertisement

Study finds weight loss drugs effective, but there’s a catch

An international review of weight-loss drug trials has found people who stop taking weight-loss medication return to original weight in less than two years.

Most diets fail because they rely on prolonged caloric restriction, which inadvertently triggers an in-built survival mechanism to fight weight loss and keep us alive during famines.

6 rules for losing weight and keeping it off

A growing school of thought says getting slimmer is more complicated than the conventional wisdom of calories in versus calories out.

Recovering addict Susan Akin considers GLP-1 drug Zepbound an essential drug like insulin.

The surprising new use for Ozempic

Some doctors are prescribing GLP-1 weight-loss drugs to help reduce cravings for alcohol and illicit drugs. But research on the benefits remains limited.

December 2025

How Ozempic is changing Christmas lunch

From roast turtle and giant cabbages to prawns and pavlova, Australian festive menus have evolved. Weight loss drugs may prompt another adjustment.

Oprah Winfrey, pictured here in Sydney last Thursday, has returned to Australia for the first time in a decade for a series of in-conversation live events sponsored by pharmaceutical company Eli Lilly.

Why Oprah Winfrey can’t discuss what brought her to Australia

Eli Lilly, the manufacturer of weight-loss drug Mounjaro, is sponsoring a series of Oprah Winfrey live events. But local laws restrict her explaining why.